相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alternative pneumocystis prophylaxis in solid organ transplant recipients at two large transplant centers
Jessica Lum et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Adverse effects of trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis pneumonia in dermatology
Hiraku Kokubu et al.
JOURNAL OF DERMATOLOGY (2021)
The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation
Pengfeng Yang et al.
MYCOSES (2021)
Lifelong, universal Pneumocystis jirovecii pneumonia prophylaxis: Patient uptake and adherence after kidney transplant
Kathryn Peterson et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Host Factors and Outcomes in Hospitalizations for Pneumocystis Jirovecii Pneumonia in the United States
Amjad Kanj et al.
MAYO CLINIC PROCEEDINGS (2021)
Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients
Seyed M. Hosseini-Moghaddam et al.
CLINICAL TRANSPLANTATION (2021)
Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study
Se Yoon Park et al.
TRANSPLANT INFECTIOUS DISEASE (2020)
Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
Amine Ghembaza et al.
CHEST (2020)
Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
G. V. Ramesh Prasad et al.
BMC INFECTIOUS DISEASES (2019)
Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Jay A. Fishman et al.
CLINICAL TRANSPLANTATION (2019)
Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome
Ji Eun Kim et al.
BMC NEPHROLOGY (2019)
Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation
Susanne Brakemeier et al.
PHARMACOLOGICAL RESEARCH (2018)
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
A. Loupy et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
High Pneumocystis jirovecii colonization rate among haemodialysis patients
Carlos Fritzsche et al.
INFECTIOUS DISEASES (2017)
Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations
Isabel Montesinos et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
Masako Utsunomiya et al.
ARTHRITIS RESEARCH & THERAPY (2017)
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients
Georg Maschmeyer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients
S. Brakemeier et al.
TRANSPLANTATION PROCEEDINGS (2016)
Pneumocystis jirovecii colonization among renal transplant recipients
Carlos Fritzsche et al.
NEPHROLOGY (2013)
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Bertram L. Kasiske et al.
KIDNEY INTERNATIONAL (2010)
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients:: Systematic review and meta-analysis of randomized controlled trials
Hefziba Green et al.
MAYO CLINIC PROCEEDINGS (2007)
分享论文
